Welcome to the Island of Misfit Toys: When Quantum Hype Meets Gold LeverageGlobal Report·1 day ago, 05:11 AMBJDX-1.04%QNME+15.99%
Bluejay Diagnostics says SYMON-II pivotal study completes enrollment of 750 patients for Symphony IL-6 testPUBT·Aug 13 at 05:05 AMBJDX-1.04%
Top Biotech Gainers: ATTO Debuts, AMWL Cuts Loss, PRGO Returns To The Black, URGN Hits New Highrttnews·Aug 5 at 10:40 PMPRGO+2.84%BJDX-1.04%
Bluejay Diagnostics Soars 51% After Intraday Dip in Heavy TradingUS Stock Market Update·Aug 5 at 01:01 PMBJDX-1.04%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Aug 5 at 12:05 PMVSEEW0.00%BJDX-1.04%
Bluejay Diagnostics surges 36% as premarket momentum carries into sessionUS Stock Market Update·Aug 5 at 10:31 AMBJDX-1.04%
Bluejay Diagnostics jumps 40% in regular trading on heavy buyingUS Stock Market Update·Aug 5 at 08:33 AMBJDX-1.04%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Aug 5 at 07:05 AMJUNS-14.52%OFIX+0.73%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Aug 4 at 04:06 PMRIGL-0.81%AMIX-5.51%
The Algorithm's Misfit Toys: A Brutal Look at 10 Market LeftoversGlobal Report·Jul 31 at 04:22 AMOIO-2.56%MGN-1.08%
Margin Over Volume: How Xylem and Levi Strauss Navigate the 2026 Earnings SeasonGlobal Report·Jul 30 at 04:14 AMENVX-6.41%LAB-1.70%
Micro-Caps Scramble for Cash as Defense Giants Lock Up Submarine DealsGlobal Report·Jul 29 at 04:19 AMBJDX-1.04%PAVS-11.44%
U.S. Equities Navigate 2026 Restructuring and M&A: A Numbers-Driven Sector RoundupGlobal Report·Jul 26 at 04:18 AMALK+0.28%UBSFY-1.92%